eFFECTOR Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EFTR and other ETFs, options, and stocks.

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). 

CEO
Stephen T. Worland
CEOStephen T. Worland
Employees
14
Employees14
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2012
Founded2012
Employees
14
Employees14

EFTR Key Statistics

Market cap
8.19M
Market cap8.19M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
—
Dividend yield—
Average volume
167.43K
Average volume167.43K
High today
$2.34
High today$2.34
Low today
$2.20
Low today$2.20
Open price
$2.25
Open price$2.25
Volume
23.54K
Volume23.54K
52 Week high
$37.00
52 Week high$37.00
52 Week low
$1.60
52 Week low$1.60
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.